Portfolio
Steps Bio is developing generic equivalents [ANDA] and differentiated formulations [505(b)(2)] to solve unmet medical needs.
These include sterile dosage forms such as
Depot formulations
Products of controlled substances
Nano-formulations: nano-emulsions and nano-suspensions
Products requiring containment: Oncology,
Steroids, Hormones, and Antibiotics
Conventional injectable and ophthalmic products
Depot formulations
Products of controlled substances
Nano-formulations: nano-emulsions and nano-suspensions
Products requiring containment: Oncology,
Steroids, Hormones, and Antibiotics
Conventional injectable and ophthalmic products